News
SAN DIEGO, May 16, 2025 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: ATYR) (“aTyr” or“the Company”), a clinical stage biotechnology company engaged ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback